Skip to main content
Fig. 2 | Journal of Orthopaedic Surgery and Research

Fig. 2

From: Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty

Fig. 2

Postoperative trends of hidden blood loss and decline of hemoglobin level. a In patients presented with non-fibrinolytic shutdown, postoperative hidden blood loss between Group A and Group B; b in patients presented with non-fibrinolytic shutdown, postoperative decline of hemoglobin level between Group A and Group B; c in patients presented with fibrinolytic shutdown, postoperative hidden blood loss between Group A and Group B; d in patients presented with fibrinolytic shutdown, postoperative decline of hemoglobin level between Group A and Group B. NFSD non-fibrinolytic shutdown, FSD fibrinolytic shutdown, HBL hidden blood loss, POD postoperative day, ΔHb decline of hemoglobin level; *p value < 0.05

Back to article page